Genmab — Juli 2019
-
så ja det er naturligvis posirivt og der skal nok være nogle enkelte kimnesere der vil nyde godt af dara. Men det betyder ikke det store i det overordnede billede
-
-
I har sikkert ret i at det ikke giver så meget som man kunne tro/håbe på.. men Kina har altså også sundhedsforsikringer, og det er et eksplosivt voksende marked. De seneste tal jeg har, viser at der er 40 millioner med en specifik cancer forsikring.. (tallet er vokset fra 1 million i 2011 til 40 mill i 2016).. går så udfra, at der er en del flere som er dækket under andre ordninger, eller selv kan betale.
-
New trial - Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM - https://clinicaltrials.gov/ct2/show/NCT04009109?term=genmab+OR+daratumumab+OR+darzalex+OR+tisotumab+OR+arzerra&lupd_s=07%2F03%2F2019&rank=2
-
InnovaTV 205 - all centers mentioned now recruiting- https://clinicaltrials.gov/ct2/history/NCT03786081?A=3&B=4&C=merged
-
hehe
-
-
Det har du ret i svak.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind